Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China. - Wikidata - wikimedia - TriplyDB

Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.

Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.

http://www.wikidata.org/entity/Q37225246

about

Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection.A cocktail of p16INK4a and Ki-67, p16INK4a and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening.

P2860

Q38819671-166907F1-1CD3-48B0-A0FF-82C3FD05BD7F Q45746736-1B5AF818-43E9-4297-82B4-435F50121A8B

P2860

Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.

http://www.wikidata.org/entity/Q37225246

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of p16/Ki-67 dual s ...... a multicenter study in China.

@en

Evaluation of p16/Ki-67 dual s ...... a multicenter study in China.

@nl

type

label

Evaluation of p16/Ki-67 dual s ...... a multicenter study in China.

@en

Evaluation of p16/Ki-67 dual s ...... a multicenter study in China.

@nl

prefLabel

Evaluation of p16/Ki-67 dual s ...... a multicenter study in China.

@en

Evaluation of p16/Ki-67 dual s ...... a multicenter study in China.

@nl

P1433

Q37225246-FB0F5696-FD3A-4438-859E-897D75234B5A

P1476

Q37225246-F3CC9A5A-EE93-4DDF-B317-CD765A4B243A

P2093

Q37225246-12BE3CB4-CC28-444F-BA6E-9D92C2E5100F

Q37225246-195851F2-A60C-4B41-B5EF-3E8EEDB14AF1

Q37225246-4D10204A-1271-4D02-B075-2E71EE31C4E9

Q37225246-653F71AD-B458-4A09-B371-ADDB46C84882

Q37225246-6D4E0E97-4261-49FB-80DB-ABB4AB9E3DE4

Q37225246-A7E9402E-73F3-485D-973C-EA60347BC67F

Q37225246-DDC692BA-8429-4839-8E5A-623BC1ED6464

Q37225246-ED2DFB1D-A538-4FFC-A919-C0269BDF74B6

Q37225246-F478D983-CFE5-4A53-B0BD-6AC3636C1EF2

P2860

Q37225246-020ABD43-AB98-4EA2-8A7B-66E70503D022

Q37225246-0B712541-DAE7-458E-8496-60BC0BE78F9F

Q37225246-1483AA45-FC45-425B-8C2D-53EC16300B6E

Q37225246-298246E4-9F70-4019-A964-E12AF04B529B

Q37225246-2D0E6C9E-77AF-412B-B69B-D0E7637E84FA

Q37225246-2DF75610-3A49-40B5-BE89-DA5CBB925788

Q37225246-34442BA9-346A-41B0-8962-00BE4BCF1F4B

Q37225246-35419734-8F5D-47A9-BD0B-C44A444CAB2E

Q37225246-3C01A72D-7FD4-47D9-9D15-13E2050E358D

Q37225246-3E306348-28ED-4FED-9A20-C7979EA2D904

P304

Q37225246-BC4ED2E5-F633-43BD-81C6-459D053D7B25

P31

Q37225246-EEA789DE-CCFC-43A9-9B17-03E9ECFA232F

P356

Q37225246-6FD7B22F-F288-43A2-B48E-5D6FC123A319

P407

Q37225246-AD214204-5684-4C77-AB35-40793DDBF646

P433

Q37225246-2838B4F7-369F-4F71-BA49-904C1C9042EB

P478

Q37225246-44FD986F-1DB6-4D74-B8BD-4F8DFD0AE4CD

P50

Q37225246-48505086-509F-4A39-A7C1-57BD0D87DAD1

Q37225246-8B294D1A-B5DF-44B3-91A2-AB281F887D15

P577

Q37225246-04AC138D-0280-4E93-B010-6B3BFFBB68A7

P5875

Q37225246-308E54ED-26C8-4ACE-82CE-D7FB0CA4D056

P698

Q37225246-87CAD23B-4DB0-4169-93D4-2410623BDBF3

P921

Q37225246-18578050-7C4D-4A4A-9DF1-8134AB62DE96

P932

Q37225246-EBCE7060-BA2E-4A78-B27C-85795E8F717B

P356

ONCOTARGET.8307

P1433

P1476

Evaluation of p16/Ki-67 dual s ...... a multicenter study in China.

@en

P2093

Bai-Feng Chang

http://www.w3.org/2001/XMLSchema#string

Hui-Qin Guo

http://www.w3.org/2001/XMLSchema#string

Lu-Lu Yu

http://www.w3.org/2001/XMLSchema#string

Qin-Jing Pan

http://www.w3.org/2001/XMLSchema#string

Shao-Kai Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Qin Lei

http://www.w3.org/2001/XMLSchema#string

Xun Zhang

http://www.w3.org/2001/XMLSchema#string

Yu Qin

http://www.w3.org/2001/XMLSchema#string

Ze-Ni Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers in cervical cancer screening

Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.

Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.

Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.

New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.

Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.

Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

P304

21181-21189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.8307

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299515410

http://www.w3.org/2001/XMLSchema#string

P698

27029033

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

5008277

http://www.w3.org/2001/XMLSchema#string